22nd Jan 2024 The effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes: a plain language summary
16th Nov 2023 Plain language summary of the EMPEROR-Preserved : drug treatment with empagliflozin was beneficial in people with heart failure with preserved ejection fraction
15th Nov 2023 A plain language summary of the EMPEROR-Reduced study: drug treatment with empagliflozin lowered risk for hospitalization in people with heart failure with reduced ejection fraction
13th Sep 2023 The effect of vibegron on the blood pressure and heart rate in people with overactive bladder: a plain language summary
20th Jul 2023 A Plain Language Summary on the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
7th Jun 2023 Plain Language Summary: the ORION-10 and ORION-11 studies look at how well inclisiran works in people with high cholesterol
12th Apr 2023 Plain Language Summary: long-term effectiveness of ARRY-371797 in people with dilated cardiomyopathy caused by a faulty LMNA gene
11th Apr 2023 Plain Language Summary: long-term survival in people being treated with tafamidis for transthyretin amyloid cardiomyopathy
27th Feb 2023 Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene
20th Sep 2022 Plain language summary of a study looking at heart muscle thickness and kidney function in women with Fabry disease who received agalsidase beta treatment
16th Mar 2022 How did transthyretin amyloid cardiomyopathy progress in patients who took placebo in the study ATTR-ACT? A plain language summary
4th Mar 2022 Is the sodium in sodium oxybate a risk for heart health? A plain language summary of publication
15th Nov 2021 Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary
21st May 2021 A plain language summary of the EXPLORER-HCM study: mavacamten for obstructive hypertrophic cardiomyopathy